Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Factor Therapeutics is a biotechnology business based in Australia. Factor Therapeutics shares (FTT) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Factor Therapeutics has a trailing 12-month revenue of around $1,794. If you're looking to buy shares, check out the steps below.
How to buy shares in Factor Therapeutics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Factor Therapeutics . Find the share by name or ticker symbol: FTT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Factor Therapeutics reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Factor Therapeutics . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
What's in this guide?
- Factor Therapeutics key stats
- Compare share trading platforms
- Is Factor Therapeutics stock a buy or sell?
- Factor Therapeutics performance over time
- Factor Therapeutics 's financials
- How volatile are Factor Therapeutics shares?
- Does Factor Therapeutics pay a dividend?
- Have Factor Therapeutics shares ever split?
- Other common questions
Factor Therapeutics stock price (ASX:FTT)
Use our graph to track the performance of FTT stocks over time.Factor Therapeutics shares at a glance
Information last updated 2021-11-10.
| 52-week range | $0.005 - $0.105 |
|---|---|
| 50-day moving average | $0.0573 |
| 200-day moving average | $0.0233 |
| Target price | $0.01 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.005 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 9 of 9
Is it a good time to buy Factor Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Factor Therapeutics price performance over time
Historical closes compared with the last close of A$0.085
| 1 year (2021-06-28) | 70.00% |
|---|---|
| 2 years (2020-06-26) | 183.33% |
| 3 years (2019-06-28) | 88.89% |
| 5 years (2017-06-28) | -86.18% |
Is Factor Therapeutics under- or over-valued?
Valuing Factor Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Factor Therapeutics 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Factor Therapeutics 's EBITDA
Factor Therapeutics 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $300,274 (£170,635).
The EBITDA is a measure of a Factor Therapeutics 's overall financial performance and is widely used to measure a its profitability.
Factor Therapeutics financials
| Revenue TTM | $1,794 |
|---|---|
| Gross profit TTM | $855,020 |
| Return on assets TTM | -9.19% |
| Return on equity TTM | -16.29% |
| Profit margin | 0% |
| Book value | 0.029 |
| Market capitalisation | $521,420 |
TTM: trailing 12 months
Factor Therapeutics share dividends
We're not expecting Factor Therapeutics to pay a dividend over the next 12 months.
Have Factor Therapeutics 's shares ever split?
Factor Therapeutics 's shares were split on a 1:10 basis on 13 September 2021. So if you had owned 10 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Factor Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Factor Therapeutics shares which in turn could have impacted Factor Therapeutics 's share price.
Factor Therapeutics share price volatility
Over the last 12 months, Factor Therapeutics 's shares have ranged in value from as little as $0.005 up to $0.105. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Factor Therapeutics 's is 0.4232. This would suggest that Factor Therapeutics 's shares are less volatile than average (for this exchange).
Factor Therapeutics overview
Dominion Minerals Limited, together with its subsidiary, engages in the exploration of mineral properties. It holds an option to purchase a high calcium limestone project located in Early County, south Georgia. The company was formerly known as Factor Therapeutics Limited and changed its name to Dominion Minerals Limited in September 2021. Dominion Minerals Limited was incorporated in 2002 and is based in Brisbane, Australia.
Stocks similar to Factor Therapeutics
Factor Therapeutics in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium shares
Steps to owning and managing Leo lithium shares.
-
How to buy Besra Gold (BEZ) shares
Steps to owning and managing Besra Gold shares.
-
How to buy The Lottery Corporation (TLC) shares
Steps to owning and managing The Lottery Corporation shares.
Ask an Expert
